6.
Moonen A, Mulders A, Defebvre L, Duits A, Flinois B, Kohler S
. Cognitive Behavioral Therapy for Anxiety in Parkinson's Disease: A Randomized Controlled Trial. Mov Disord. 2021; 36(11):2539-2548.
PMC: 9290129.
DOI: 10.1002/mds.28533.
View
7.
Chen P, Guarino P, Dysken M, Pallaki M, Asthana S, Llorente M
. Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer's Disease: The TEAM-AD VA Cooperative Study. J Geriatr Psychiatry Neurol. 2018; 31(4):177-185.
DOI: 10.1177/0891988718783897.
View
8.
Egan S, Laidlaw K, Starkstein S
. Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease. J Parkinsons Dis. 2015; 5(3):443-51.
PMC: 4923758.
DOI: 10.3233/JPD-150542.
View
9.
Robert P, Lanctot K, Aguera-Ortiz L, Aalten P, Bremond F, Defrancesco M
. Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur Psychiatry. 2018; 54:71-76.
DOI: 10.1016/j.eurpsy.2018.07.008.
View
10.
Aarsland D, Larsen J, Lim N, Janvin C, Karlsen K, Tandberg E
. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999; 67(4):492-6.
PMC: 1736593.
DOI: 10.1136/jnnp.67.4.492.
View
11.
Le Heron C, Apps M, Husain M
. The anatomy of apathy: A neurocognitive framework for amotivated behaviour. Neuropsychologia. 2017; 118(Pt B):54-67.
PMC: 6200857.
DOI: 10.1016/j.neuropsychologia.2017.07.003.
View
12.
Aarsland D, Marsh L, Schrag A
. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord. 2009; 24(15):2175-86.
PMC: 2787875.
DOI: 10.1002/mds.22589.
View
13.
Lanctot K, Ismail Z, Bawa K, Cummings J, Husain M, Mortby M
. Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders. Int J Geriatr Psychiatry. 2023; 38(2):e5882.
PMC: 10107127.
DOI: 10.1002/gps.5882.
View
14.
Jordan L, Zahodne L, Okun M, Bowers D
. Hedonic and behavioral deficits associated with apathy in Parkinson's disease: potential treatment implications. Mov Disord. 2013; 28(9):1301-4.
PMC: 3760996.
DOI: 10.1002/mds.25496.
View
15.
Klingelhoefer L, Reichmann H
. Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors. Nat Rev Neurol. 2015; 11(11):625-36.
DOI: 10.1038/nrneurol.2015.197.
View
16.
Renner F, Ji J, Pictet A, Holmes E, Blackwell S
. Effects of Engaging in Repeated Mental Imagery of Future Positive Events on Behavioural Activation in Individuals with Major Depressive Disorder. Cognit Ther Res. 2017; 41(3):369-380.
PMC: 5410208.
DOI: 10.1007/s10608-016-9776-y.
View
17.
Sinha N, Manohar S, Husain M
. Impulsivity and apathy in Parkinson's disease. J Neuropsychol. 2013; 7(2):255-83.
PMC: 3836240.
DOI: 10.1111/jnp.12013.
View
18.
Thobois S, Lhommee E, Klinger H, Ardouin C, Schmitt E, Bichon A
. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain. 2013; 136(Pt 5):1568-77.
DOI: 10.1093/brain/awt067.
View
19.
Pluck G, Brown R
. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002; 73(6):636-42.
PMC: 1757348.
DOI: 10.1136/jnnp.73.6.636.
View
20.
Butterfield L, Cimino C, Salazar R, Sanchez-Ramos J, Bowers D, Okun M
. The Parkinson's Active Living (PAL) Program. J Geriatr Psychiatry Neurol. 2017; 30(1):11-25.
DOI: 10.1177/0891988716673467.
View